Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

David J Inwards

6PUBLICATIONS
28CO-AUTHORS
Haematological tumoursAutoimmunityPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jan 02, 2023
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

Karan L Chohan, Jonas Paludo, Nishanth Vallumsetla

|Jul 14, 2021
Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin's lymphoma.

Arushi Khurana, Matthew Hathcock, Thomas M Habermann

|May 13, 2021
Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis.

Arushi Khurana, Joanna C Dalland, Jason R Young

|May 10, 2021
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

Nicholas J Boddicker, Melissa C Larson, Alessia Castellino

|Apr 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia.

Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell

|Feb 04, 2021
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis.

Gaurav Goyal, Jithma P Abeykoon, Marie Hu

Pageof 1

Frequent Collaborators

4 joint publications

Jonas Paludo

3 joint publications

Stephen M Ansell

3 joint publications

Thomas E Witzig

2 joint publications

Jithma P Abeykoon

2 joint publications

Shaji Kumar

2 joint publications

Rong He

2 joint publications

Morie A Gertz

2 joint publications

Sikander Ailawadhi

2 joint publications

Sundararajan Vincent Rajkumar

2 joint publications

Wilson Gonsalves

Frequent Collaborators

4 joint publications

Jonas Paludo

3 joint publications

Stephen M Ansell

3 joint publications

Thomas E Witzig

2 joint publications

Jithma P Abeykoon

Top Related Videos

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on : Mar 29, 2017

11.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

922
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

3.6K
See more related videos

Top Related Videos

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on : Mar 29, 2017

11.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

922
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on : Feb 17, 2022

3.6K
See more related videos